← Leaderboards
Mark Hatherill
University Of Cape Town
$4,643,241
Attributed
$4,748,241
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $903.5K · FY2007–24$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$4,748,241 · 4
By mechanism
R01$4,376,659 · 2
U01$210,000 · 1
R34$161,582 · 1
Top collaborators
- Ann M Ginsberg1 shared
Most similar at University Of Cape Town
Same institution · by research overlap
- Elisa Nemes$3,140,207
- Willem Albert Hanekom$4,473,214
- Thomas Jens Scriba$2,251,744
- Anna-Ursula Happel$521,886
Others in their field
Top investigators on “Tuberculosis Vaccines”
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$297,204,160
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$267,912,117
- Lawrence Corey · Fred Hutchinson Cancer Center$255,939,398
- Sharon A Nachman · Johns Hopkins University$191,372,062
- Judith S. Currier · University Of California Los Angeles$165,334,736
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$159,744,987
Research focus
Tuberculosis VaccinesTuberculosisMycobacterium TuberculosisIncidenceAdolescentAdultChildEnrollmentCostResearch PersonnelEvaluationCommunitiesDiagnosticDiagnosisLaboratoriesInvestigationBaseDetectionSamplingSiteSouth AfricaInfantBcg VaccineImmune Response
Grant awards (12)
Host blood biomarkers for the diagnosis prognosis and treatment response of childhood TB$806,919
R01 · FY2024 · AI · contact PI
Host blood biomarkers for the diagnosis prognosis and treatment response of childhood TB$794,603
R01 · FY2023 · AI · contact PI
Host blood biomarkers for the diagnosis prognosis and treatment response of childhood TB$808,450
R01 · FY2021 · AI · contact PI
Host blood biomarkers for the diagnosis prognosis and treatment response of childhood TB$903,535
R01 · FY2020 · AI · contact PI
Host blood biomarkers for the diagnosis prognosis and treatment response of childhood TB$653,408
R01 · FY2019 · AI · contact PI
MTBVAC Phase 1b/2a Randomized, Double-blind, Active-controlled, Safety, Immunogenicity, and Dose-escalation Study in Adults with and without Latent Tuberculosis Infection in South Africa$210,000
U01 · FY2017 · AI
A double-blind randomized controlled Phase IIb trial of safety and immunogenicity$161,582
R34 · FY2013 · AI · contact PI
Diagnostic yield of induced sputum for rapid diagnosis of pulmonary tuberculosis$91,156
R01 · FY2011 · AI · contact PI
Diagnostic yield of induced sputum for rapid diagnosis of pulmonary tuberculosis$78,666
R01 · FY2010 · AI · contact PI
Diagnostic yield of induced sputum for rapid diagnosis of pulmonary tuberculosis$79,461
R01 · FY2009 · AI · contact PI
Diagnostic yield of induced sputum for rapid diagnosis of pulmonary tuberculosis$79,461
R01 · FY2008 · AI · contact PI
Diagnostic yield of induced sputum for rapid diagnosis of pulmonary tuberculosis$81,000
R01 · FY2007 · AI · contact PI